Cargando…
Time from last immunity event against infection during Omicron-dominant period in Malaysia
OBJECTIVES: To study the incidence of Omicron infections in Malaysia and the exposures that could reduce the hazard of attaining Omicron infection. METHODS: We used a multicenter, prospective cohort to study 482 healthcare workers vaccinated with two and three doses of BNT162b2 for SARS-CoV-2 infect...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791788/ https://www.ncbi.nlm.nih.gov/pubmed/36581187 http://dx.doi.org/10.1016/j.ijid.2022.12.025 |
_version_ | 1784859487747702784 |
---|---|
author | Yang, Su Lan Ripen, Adiratna Mat Lee, Jen Ven Koh, Karina Yen, Chia How Chand, Avinash Kumar Abdul Rahim, Nur Aisyah Binti Gokilavanan, Varaalakshmy Mohamed, Nik Nur Eliza Binti Sevalingam, Raj Kumar A/L Peariasamy, Kalaiarasu M. |
author_facet | Yang, Su Lan Ripen, Adiratna Mat Lee, Jen Ven Koh, Karina Yen, Chia How Chand, Avinash Kumar Abdul Rahim, Nur Aisyah Binti Gokilavanan, Varaalakshmy Mohamed, Nik Nur Eliza Binti Sevalingam, Raj Kumar A/L Peariasamy, Kalaiarasu M. |
author_sort | Yang, Su Lan |
collection | PubMed |
description | OBJECTIVES: To study the incidence of Omicron infections in Malaysia and the exposures that could reduce the hazard of attaining Omicron infection. METHODS: We used a multicenter, prospective cohort to study 482 healthcare workers vaccinated with two and three doses of BNT162b2 for SARS-CoV-2 infection during the Omicron-dominant period in Malaysia. RESULTS: Between January 31 and July 31, 2022, the cumulative incidence was 44.6% (95% CI 40.2-49.1%), and the incidence rate was 3.33 (95% CI 2.91-3.80) per 1000 person-days. Our study found that protection against Omicron infection was significantly higher for persons with previous SARS-CoV-2 infection (hazard ratio [HR] 0.41, 95% CI 0.27-0.62) and persons with a more recent immunity event (<30 days [reference] vs >90 days, HR 3.82, 95%CI 1.34-10.90) from the beginning of the Omicron period. CONCLUSION: Pre-Omicron natural infection and a recent immunity event protect against future Omicron infections. |
format | Online Article Text |
id | pubmed-9791788 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97917882022-12-27 Time from last immunity event against infection during Omicron-dominant period in Malaysia Yang, Su Lan Ripen, Adiratna Mat Lee, Jen Ven Koh, Karina Yen, Chia How Chand, Avinash Kumar Abdul Rahim, Nur Aisyah Binti Gokilavanan, Varaalakshmy Mohamed, Nik Nur Eliza Binti Sevalingam, Raj Kumar A/L Peariasamy, Kalaiarasu M. Int J Infect Dis Short Communication OBJECTIVES: To study the incidence of Omicron infections in Malaysia and the exposures that could reduce the hazard of attaining Omicron infection. METHODS: We used a multicenter, prospective cohort to study 482 healthcare workers vaccinated with two and three doses of BNT162b2 for SARS-CoV-2 infection during the Omicron-dominant period in Malaysia. RESULTS: Between January 31 and July 31, 2022, the cumulative incidence was 44.6% (95% CI 40.2-49.1%), and the incidence rate was 3.33 (95% CI 2.91-3.80) per 1000 person-days. Our study found that protection against Omicron infection was significantly higher for persons with previous SARS-CoV-2 infection (hazard ratio [HR] 0.41, 95% CI 0.27-0.62) and persons with a more recent immunity event (<30 days [reference] vs >90 days, HR 3.82, 95%CI 1.34-10.90) from the beginning of the Omicron period. CONCLUSION: Pre-Omicron natural infection and a recent immunity event protect against future Omicron infections. The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2023-03 2022-12-26 /pmc/articles/PMC9791788/ /pubmed/36581187 http://dx.doi.org/10.1016/j.ijid.2022.12.025 Text en © 2022 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Short Communication Yang, Su Lan Ripen, Adiratna Mat Lee, Jen Ven Koh, Karina Yen, Chia How Chand, Avinash Kumar Abdul Rahim, Nur Aisyah Binti Gokilavanan, Varaalakshmy Mohamed, Nik Nur Eliza Binti Sevalingam, Raj Kumar A/L Peariasamy, Kalaiarasu M. Time from last immunity event against infection during Omicron-dominant period in Malaysia |
title | Time from last immunity event against infection during Omicron-dominant period in Malaysia |
title_full | Time from last immunity event against infection during Omicron-dominant period in Malaysia |
title_fullStr | Time from last immunity event against infection during Omicron-dominant period in Malaysia |
title_full_unstemmed | Time from last immunity event against infection during Omicron-dominant period in Malaysia |
title_short | Time from last immunity event against infection during Omicron-dominant period in Malaysia |
title_sort | time from last immunity event against infection during omicron-dominant period in malaysia |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791788/ https://www.ncbi.nlm.nih.gov/pubmed/36581187 http://dx.doi.org/10.1016/j.ijid.2022.12.025 |
work_keys_str_mv | AT yangsulan timefromlastimmunityeventagainstinfectionduringomicrondominantperiodinmalaysia AT ripenadiratnamat timefromlastimmunityeventagainstinfectionduringomicrondominantperiodinmalaysia AT leejenven timefromlastimmunityeventagainstinfectionduringomicrondominantperiodinmalaysia AT kohkarina timefromlastimmunityeventagainstinfectionduringomicrondominantperiodinmalaysia AT yenchiahow timefromlastimmunityeventagainstinfectionduringomicrondominantperiodinmalaysia AT chandavinashkumar timefromlastimmunityeventagainstinfectionduringomicrondominantperiodinmalaysia AT abdulrahimnuraisyahbinti timefromlastimmunityeventagainstinfectionduringomicrondominantperiodinmalaysia AT gokilavananvaraalakshmy timefromlastimmunityeventagainstinfectionduringomicrondominantperiodinmalaysia AT mohamedniknurelizabinti timefromlastimmunityeventagainstinfectionduringomicrondominantperiodinmalaysia AT sevalingamrajkumaral timefromlastimmunityeventagainstinfectionduringomicrondominantperiodinmalaysia AT peariasamykalaiarasum timefromlastimmunityeventagainstinfectionduringomicrondominantperiodinmalaysia |